Symmetrical Triazine Herbicides: A Review of Regulatory Toxicity Endpoints

Hayes' Handbook of Pesticide Toxicology

Volumn , Issue , 2010, Pages 1711-1723

  Breckenridge, Charles B ^a   Charles Eldridge, J ^b   Stevens, James T ^b   Simpkins, James W ^c  

^a SYNGENTA CROP PROTECTION   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864312470     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374367-1.00079-3     Document Type: Chapter

References (67)

1. Alavanja M.C.R., Samanic C., Dosemeci M., Lubin J., Tarone R., Lynch C.F., Knott C., Thomas K., Hoppin J.A., Barker J., Coble J., Sandler D.P., Blair A. Use of agricultural pesticides and prostate cancer risk in the agricultural health study cohort. Am. J. Epidem. 2003, 157(9):800-814.
2. APVMA (formerly the National Registrations Authority for Agriculture and Veterinary Chemicals). (1997). The NRA Review of atrazine, November 1997.
3. APVMA (2004). The reconsideration of approvals of the active constituent atrazine. Registrations of products containing atrazine and their associated labels. October 2004.
4. APVMA (2008). Atrazine. Final Review Report and Regulatory Decision. Volume 1. March, 2008. http://www.apvma.gov.au/chemrev/downloads/atrazine_finalMay08.pdf.
5. Blair A., Sandler D., Thomas K., Hoppin J.A., Kamel F., Coble J., Lee W.J., Ruslecki J., Knott C., Dosemeci M., Lynch C.F., Lubin J., Alavanja M. Disease and injury among participants in the agricultural health study. J. Agri. Safety Health 2005, 1l(2):141-150.
6. Bliley, R. (1996). Food Quality Protection Act of 1996. 104 Congress, 2nd Session. Report 104-669, part 2, pp. 1-89. Government Printing Office, Washington, DC.
7. Bogdanffy, M. S., O'Connor, J. C., Hansen, J. F., Gaddamidi, V., Van Pelt, C. S., and Cook, J. C. (2000). Chronic toxicity and oncogenicity bioassay in rats with the chloro-S-triazine herbicide cyanazine. J. Toxicol. Environ. Health Accepted for publication.
8. Breckenridge, C. B., Werner, C., Stevens, J. T. and Sumner, (2008). Hazard Assessment for selected Symmetrical and Asymmetrical Triazine Herbicides. Chapter 26. In "The Triazine Herbicides" (H.M. Le Baron, McFarland, O. Burnside, and R. Clark, eds.), pp. 346-358.
9. Brusick D.J. An assessment of the genetic toxicity of atrazine: Relevance to health and effects. Mutation Res. 1994, 317:133-144.
10. Cooper R.L., Parrish M.B., McElroy W.K., Rehnberg G.L., Hein J.F., Goldmann J.M., Stoker T., Tyrey L. Effect of atrazine on the hormonal control of the ovary. The Toxicologist 1995, 15:294.
11. Cutts J.H., Noble R.L. Estrone-induced mammary tumors in the rat. II. Effect of alteration in hormonal environment on tumor induction, behavior, and growth. Cancer Res. 1964, 24:1124-1130.
12. De Roos A.J., Zahm S.H., Cantor K.P., Weisenburger D.D., Holmes F.F., Burmeister L.L. Integrative assessment of multiple pesticides as risk factors for non-Hodgkin's lymphoma among men. Occup. Environ. Med. 2003, 60:1-9.
13. Eldridge J.C., Stevens J.T., Wetzel L.T., Tisdel M.O., Breckenridge C.B., McConnell R.F., Simpkins J.W. Atrazine: Mechanisms of hormonal imbalance in female SD rats. Fund. Appl. Toxicol. 1996, 24(12):2-5.
14. Eldridge J.C., McConnell R.F., Wetzel L.T., Tisdel M.O. Appearance of mammary tumors in atrazine-treated female rats: Probable mode of action involving strain-related control of ovulation and estrous cycling. Triazine Herbicides: Risk Assessment 1998, 414-423. Chap. 32, American Chemical Society, Washington, DC. L.G. Ballantine, J.E. McFarland, D.S. Hackett (Eds.).
15. Eldridge J.C., Wetzel L.T., Tyrey L. Estrous cycle patterns of Sprague-Dawley rats during acute and chronic atrazine administration. Reprod. Toxicol. 1999, 13:491-499.
16. Eldridge J.C., Stevens J.T., Breckenridge C.B. Atrazine interaction with estrogen expression systems. Rev. Environ. Contam. Toxicol. 2007, 196:147-160. Review.
17. Eldridge, J. C., and Wetzel, L. T. (2008). Mode of Action of Atrazine for Mammary Tumor Formation in the Female Sprague-Dawley Rat. Chapter 26. In "The Triazine Herbicides" (H.M. Le Baron, McFarland, O. Burnside, and R. Clark, eds.), pp. 399-411.
18. Engel L.S., Hill D.A., Hoppin J.A., Lubin J.H., Lynch C.J., Pierce J., Samanic C., Sandler D.P., Blair A., Alavanja M.C. Pesticide use and breast cancer risk among farmers' wives in the agricultural health study. Am. J. Epidemiol. 2005, 161(2):121-135.
19. Farber, T. M. (1987). "Pesticide Assessment Guidelines, Subdivision F, Position Document: Selection of a Maximum Tolerated Dose (MTD) in Oncogenicity Studies." Toxicology Branch, Hazard Evaluation Division, Office of Pesticides Programs, U.S. Environmental Protection Agency, NTIS PB88-116736.
20. Foran J. Principles for the selection of doses in chronic rodent bioassays. Environ. Health Perspect. 1997, 105(1):18-20. the ILSI Risk Science Working Group on Dose Selection.
21. French Republic Ministry of Agriculture. (2001). Triazine-based specialties - intended decision. Report by the Toxicity Research Commission on Pesticide Products.
22. Gressel J., Ammon H.U., Fogelfors H., Gasquez J., Kay Q.O.N., Kees H. Discovery and distribution of herbicide-resistant weeds outside of North America. Herbicide Resistance in Plants 1982, 31-46. Wiley, New York. H.M. LeBaron, J. Gressel (Eds.).
23. Hauswirth J.W., Wetzel L.T. Toxicity characteristics of the 2-chlorotriazines, atrazine and simazine. Triazine Herbicides: Risk Assessment 1998, 370-383. American Chemical Society, Washington, DC. L.G. Ballantine, J.E. McFarland, D.S. Hackett (Eds.).
24. Hessel P.A., Kalmes R., Smith T.J., Lau E., Mink P.J., Mandel J. A nested case control study of prostate cancer and atrazine exposure. J. Occup. Environ. Med. 2004, 46(4):379-385.
25. Hopenhayn-Rich C., Stump M.L., Browning S.R. Regional assessment of atrazine exposure and incidence of breast and ovarian cancer in Kentucky. Arch. Environ. Contam. Toxicol. 2002, 42:127-136.
26. Integrated Risk Information System (IRIS). (1997a). Propazine. Chem. Abst. Service Reg. No. CASRN 139-40-2. USEPA. pp. 1-7.
27. International Agency for Research on Cancer (IARC). (1999). Atrazine. Volume 73. Some Chemicals that Cause Tumours of the Kidney or Urinary Bladder in Rodents and Some Other Substances. p. 59.
28. Jessup, D. C. (1980). "Terbutryn Technical Two-Year Carcinogenicity Study in Mice." Project Rep. 382-005, International Research and Development Corporation. Mattawan, MI (unpublished).
29. JMPR. (2007). Pesticide residues in food 2007. Joint FAO/WHO Meeting on Pesticide Residues. FAO Plant Production and Protection Paper 191.
30. Kettles M.A., Browning S.R., Prince T.S., Horstman S.W. Triazine herbicide exposure and breast cancer incidence: an ecologic study of Kentucky counties. Environ. Health Perspect. 1997, 105(11):1222-1227.
31. Lebaron, H. M., McFarland, J. E., and Burnside, O. C. (2008). The Triazine Herbicides: A Milestone in the Development of Weed Control Technology. Chapter 1. In "The Triazine Herbicides," (H. M. Le Baron, McFarland, O. Burnside, and R. Clark, eds.), pp. 1-12.
32. Loosli R. Epidemiology of atrazine. Rev. Environ. Contam. Toxicol. 1995, 143:47-57.
33. MacLennan P., Delzell E., Sathiakumar N., Meyers S.L., Cheng H., Grizzle W., Chen V.W., Wu X.C. Cancer incidence among triazine herbicide manufacturing workers. J. Occup. Environ. Med. 2002, 44(11):1048-1058.
34. Mills P.K. Correlation analysis of pesticide use data and cancer incidence rates in California counties. Arch. Environ. Health 1998, 53(6):410-413.
35. Mills P.K., Yang R. Prostate cancer risk in California farm workers. J. Occup. Environ. Med. 2003, 45(3):249-258.
36. Muir K., Rattanamongkogul S., Smallman-Raynor M., Thomas M., Downer S., Jenkinson C. Breast cancer incidence and its possible spatial association with pesticide application in two counties of England. Public Health 2004, 118:513-520.
37. Neuberger J.S. Atrazine and/or triazine herbicides exposure and cancer: An epidemiologic review. J. Agromed. 1996, 3(2):9-30.
38. Osheroff, M. R. (1998). Lifetime oncogenicity study in mice with prometon technical. Hazleton Laboratories Inc. Technical Report.
39. Rusiecki J.A., De Roos A., Lee W.J., Dosemeci M., Lubin J.H., Hoppin J.A., Blair A., Alavanja M.C. Cancer incidence among pesticide applicators exposed to atrazine in the Agricultural Health Study. J. Natl. Cancer Inst. 2004, 96:1375-1382.
40. Sathiakumur N., Delzell E., Austin H., Cole P. A follow-up study of agricultural chemical production workers. Am. J. Ind. Med. 1992, 21:321-330.
41. Sathiakumur N., Delzell E. A Review of Epidemiologic Studies of Triazine Herbicides and Cancer. Crit. Rev. Toxicol. 1997, 27:599-612.
42. Sielken, R. L., Valdez-Flores, C., Breckenridge, C., and Stevens, J. (2005). Statistical Inference about the Mechanism of Action in Health, 31, Supplement 1, 151-155.
43. Simpkins J.W., Eldridge J.C., Wetzel L.T. Role of strain-specific reproductive patterns in the appearance of mammary tumors in atrazine-treated rats. Triazine Herbicides: Risk Assessment 1998, 399-413. Chap. 31, American Chemical Society, Washington, DC. L.G. Ballantine, J.E. McFarland, D.S. Hackett (Eds.).
44. Stevens J.T., Breckenridge C.B., Wetzel L.T., Gillis J., Luempert L.C. Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides. J. Toxicol. Environ. Health 1994, 43:139-153.
45. Stevens J.T., Breckenridge C.B., Wetzel L.T., Thakur A.J., Liu C., Werner C., Luempert L.C., Eldridge J.C. A risk characterization for atrazine: Oncogenicity profile. J. Toxicol. Environ. Health 1999, 56:69-109.
46. Sumner D.D., Luempert L.C., Stevens J.T. Agricultural chemicals: The impact of regulation under FIFRA on science and economics. Primer on Regulatory Toxicology 1995, 133-163. Raven Press, New York. C. Chenzelis, J. Holson, S. Gad (Eds.).
47. Swindell R. Shining light on the evolution of photosynthesis. Answers Magazine 2003, 17(3):74-84. http://images.google.com/imgres?imgurl=http://www.answersingenesis.org/t j/images/v17/i3/photosynthesis_f5.jpg&imgrefurl=http://www.answersin genesis.org/tj/v17/i3/photosynthesis.asp&usg=__J8IDo252ZPUvKv3tNYm5x C75nek=&h=306&w=438&sz=33&hl=en&start=71&um=1&tbnid=CQYsTlqyH35hhM:&tbnh=89&tbnw=127&prev=/images%3Fq%3D photosystem%2BII,%2BD1%2Bprotein%26ndsp%3D20%26hl%3Den%26sa%3DN%26start% 3D60%26um%3D1.
48. Thakur A.J., Wetzel L.T., Voelker R.W., Wakefield A.E. Results of a two-year oncogenicity study in Fischer 344 rats with atrazine. Triazine Herbicides: Risk Assessment 1998, 384-398. American Chemical Society, Washington, DC. L.G. Ballantine, J.E. McFarland, D.S. Hackett (Eds.).
49. Trebst, A. (2008). The Mode of Action of Triazine Herbicides in Plants. In "The Triazine Herbicides," (H. M. Le Baron, McFarland, O. Burnside, and R. Clark, eds.), pp. 101-118.
50. UK. (2007). Terbuthylazine: Report and proposed decision of the United Kingdom made to the European Commission under Article 8 of 91/414/EEC. Level 2. Appendix 3: List of Endpoints. August draft.
51. UK Rapporteur Monograph. (2000). Council Directive 91/414/EEC. Regulation 3600/92. Atrazine, Volume 3. Annex B. Addendum to the report and proposed decision of the United Kingdom made to the European Commission under Article 7(1) of Regulation 3600/92; Summary, Scientific Evaluation and Assessment.
52. Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); Good Laboratory Practice Standards"Final Rules. 40 CFR Part 160. Fed. Reg. 1979, 44(91):27362-27407. U.S. EPA.
53. U.S. EPA (1982). "Pesticide Assessment Guidelines, Subdivision F. Hazard Evaluation: Human and Domestic Animals." Environmental Protection Agency-540/9-82-025. Available from NTIS, Springfield, VA.
54. Atrazine, simazine, and cyanazine; Notice of initiation of special review. Fed. Reg. 1994, 59(225):60412-60443. U.S. EPA.
55. U.S. EPA (1995). Terbuthylazine Reregistration Eligibility Decision. EPA 738-R-95-005. http://www.epa.gov/oppsrrd1/REDs/2645.pdf.
56. U.S. EPA (1996). Prometryn Registration Eligibility Decision. EPA-738-R-95-033. http://www.epa.gov/oppsrrd1/REDs/0467.pdf.
57. U.S. EPA (1998a). "Pesticide Assessment Guidelines," Health Effects Test Guidelines/Series (accessed 3/99). http://www.epa.gov/opptsfrs/OPPTSHarmonized/870.
58. U.S. EPA (2000). Atrazine. Hazard and Dose-Response Assessment and Characterization. SAP Report No. 2000-05. FIFRA Scientific Advisory Panel. June 27-29, 2000.
59. U.S. EPA (2002). Overview of Atrazine Risk Assessment. http://www.epa.gov/oppsrrdI/Reregistration/atrazine/srrdoverview_may02.p df.
60. U.S. EPA (2003a). Atrazine. Interim Reregistration Eligibility Decision (IRED). Docket Number 0062.
61. U.S. EPA (2003b). Revised Atrazine interim Reregistration Eligibility Decision (IRED). Docket ID Number OPP-2003-0367.
62. U.S. EPA (2004). Ametryn: HED Chapter of the Reregistration Eligibility Decision. http://www.epa.gov/oppsrrd1/REDs/ametryn_red.pdf.
63. U.S. EPA (2006a). Cancer Assessment Review Committee, Atrazine: Evaluation of carcinogenic potential. HED DOC. No. 014431.
64. U.S. EPA (2006b). Reregistration Eligibility Decision for Simazine. EPA 738-R-06-008. April 2006. http://www.epa.gov/oppsrrd1/REDs/simazine_red.pdf.
65. Van Leeuwen J.A., Walmer-Toews D., Abernathy T., Smit B., Shoukri M. Associations between stomach cancer incidence and drinking water contamination with atrazine and nitrate in Ontario (Canada) agmecosysterns. 1987-1991. Int. J. Epidem. 1999, 28(5):836-840.
66. Weisburger, J. H. (1975). In "Toxicology, The Basic Science of Poisons," (L. J. Casarett, and J. Duoll, eds.), MacMillan, New York, p. 333.
67. Wetzel L.T., Luempert L.G., Breckenridge C.B., Tisdell M.O., Stevens J.T., Thakur A.K., Extrom P.J., Eldridge J.C. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawky and Fischer 344 rats. J. Toxicol. Environ. Health 1994, 43:169-182.